financetom
Business
financetom
/
Business
/
EU's Vestager may act if Microsoft's poaching of Inflection staff signals wider trend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU's Vestager may act if Microsoft's poaching of Inflection staff signals wider trend
Apr 3, 2024 10:20 AM

BRUSSELS (Reuters) - EU regulators have noted Microsoft's ( MSFT ) hiring of most of artificial intelligence startup Inflection's staff including its co-founders and may act if other companies act similarly, making it a trend, EU antitrust chief Margrethe Vestager said on Wednesday.

Microsoft ( MSFT ) last month hired co-founders Mustafa Suleyman and Karen Simonyan and most of Inflection's 70-strong team for a newly created unit called Microsoft AI, as the U.S. software giant consolidates and expands its AI offerings for consumer products.

The move triggered criticism from rivals as the talent and technology transfer meant Microsoft ( MSFT ) avoided the regulatory scrutiny that comes with a traditional acquisition.

Vestager said she was following developments.

"It is the kind of thing on which we keep an eye but as you say, since it is not a merger it is not caught by merger rules," she told reporters.

"We might (look into it) but we have no decisions, neither to do something or not do something. We have registered that this is happening and also registering that it's happening in a way so that it escapes our scrutiny from our usual boxes," she said.

Microsoft ( MSFT ) declined to comment.

There could be concerns if other companies follow suit, Vestager added.

"Of course if things become a trend and if that trend seems to be something that circumvents what has been put in place to preserve competition, which is merger rules, of course that could be restored and eventually corrected," Vestager said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Church & Dwight Maintains Quarterly Dividend at $0.28375 a Share, Payable Dec. 2 to Shareholders of Record Nov. 15
--Church & Dwight Maintains Quarterly Dividend at $0.28375 a Share, Payable Dec. 2 to Shareholders of Record Nov. 15
Nov 3, 2024
12:00 PM EDT, 10/30/2024 (MT Newswires) -- Price: 100.42, Change: -0.21, Percent Change: -0.21 ...
Update: Signal Gold Down 5% as It Provides Final Drill Results from the Western Extension of the Goldboro Deposit
Update: Signal Gold Down 5% as It Provides Final Drill Results from the Western Extension of the Goldboro Deposit
Nov 3, 2024
12:03 PM EDT, 10/30/2024 (MT Newswires) -- Signal Gold ( SGNLF ) reported Wednesday final assay results from its 5,179-meter diamond-drilling program at the western extension of its Goldboro project in Nova Scotia. Results included 7.56 grams per tonne (g/t) gold over 1.9 meters and 3.80 g/t gold over 3.0 meters. We are excited with these final results, in addition...
Update: SECURE Energy Up 9% as Its Q3 Profit Doubles; Reaffirms 2024 Adjusted EBITDA Guidance
Update: SECURE Energy Up 9% as Its Q3 Profit Doubles; Reaffirms 2024 Adjusted EBITDA Guidance
Nov 3, 2024
12:00 PM EDT, 10/30/2024 (MT Newswires) -- SECURE Energy Services ( SECYF ) on Wednesday said its third-quarter profit doubled on higher revenue. The waste management and energy infrastructure company earned $94 million, or $0.39 per share, in the period, up from $47 million, or $0.16, in the year-prior quarter. Revenue rose to $2.61 billion from $2.22 billion while adjusted...
What's Going On With Tharimmune Shares Wednesday?
What's Going On With Tharimmune Shares Wednesday?
Nov 3, 2024
Tharimmune, Inc. ( THAR ) shares are moving higher Wednesday after the company announced it received overall positive feedback from the European Medicines Agency (EMA) on its TH104 clinical program. What To Know: TH104 is the company’s lead clinical-stage candidate for treating moderate-to-serve pruritus in primary biliary cholangitis. The EMA interactions specifically focused on both the Phase 2 and Phase 3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved